Growth Screen For The Week Of 10/19/2015

21 Oct

Growth Screen For The Week Of 10/19/2015

The results of ValueWalk’s growth screen for the week of 10/19/2015.

Using data is provided by Winvestor, the business analysis and stock valuation website, we’ve put together a proprietary growth screen to help you select the best growth stocks in the current market.

Winvestor uses financial data from Thomson . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible

Rupert Hargreaves

Sign up now and get our in-depth FREE e-books on famous investors like Klarman, Dalio, Schloss, Munger Rupert is a committed value investor and regularly writes and invests following the principles set out by Benjamin Graham. He is the editor and co-owner of Hidden Value Stocks, a quarterly investment newsletter aimed at institutional investors. Rupert owns shares in Berkshire Hathaway. Rupert holds qualifications from the Chartered Institute For Securities & Investment and the CFA Society of the UK. Rupert covers everything value investing for ValueWalk

19 Apr

The 11 Most Active VC Investors In Cleantech

By VW Staff

The 11 Most Active VC Investors In Cleantech by Mikey Tom, PitchBook There was a period of time in the not-so-distant past when cleantech appeared to be the next great frontier for... read more

14 May

Best Buy Co., Inc. (BBY) Chairman Leaves After Many Painful Years

By VW Staff

On Monday, Best Buy Co., Inc. (NYSE:BBY) announced that its founder and Chairman of the Board Richard Schulze will leave after failing to tell the board of allegations that former Chief Executive... read more

10 May

Chesapeake Troubles Continue As Pipeline Gains Steam

By VW Staff

Chesapeake Energy Corporation (NYSE:CHK) is facing trouble on Wall Street just as it's subsidiary Chesapeake Midstream Partners L.P. (NYSE:CHKM) is seeing more and more interest in its future. Reuters today reported... read more

17 Sep

Hedge Funds Lost $6.3 Billion In August: Eurekahedge

By VW Staff

August was not an easy month for even the biggest hedge funds. Uncertainty in the global economy stemming from taper talk at the Federal Reserve and war drums at... read more

17 Jun

Investment Banking Weakens As Volatility Spikes

By VW Staff

Investment banking, after five long, hard years of negative or anemic growth, job cuts, pay cuts and public lashings, is on the verge of a comeback. Really, it is—if... read more

13 Jun

In Gold We Trust!

By Ritesh Jain

Money is most vulnerable to level of public trust. Federal Reserve under Paul Volcker restored confidence through a restrictive monetary policy that led to high interest rates which is... read more

07 May

Whitney Tilson's Bullish Presentation on AIG

By VW Staff

Snapshot: • American International Group, Inc. (NYSE:AIG) is a leading global multi-line insurance company with well-managed, sustainable global franchises • AIG today is far different from the risky pre-crisis AIG • Lingering taint from the... read more

09 Jan

300+ Book Recommendations From Mohnish Pabrai

By Jacob Wolinsky

UPDATED: 01/09/2018 at 1:50PM EST While we are updating our books list one investor readers asked us about was Mohnish Pabrai. When we looked into it turned out Pabrai... read more

17 Dec

Welling On Wall Street Interview With Boyar Value Group

By VW Staff

Welling on Wall Street recently interviewed Boyar Value Group's Mark Boyar and Jonathan Boyar and talked about various topics including: their investment strategy, some of their current favorite stock... read more

29 Oct

Ruane, Cunniff & Goldfarb Letter: Valeant, As A Real Life Experience, It Hurts

By VW Staff

Ruane, Cunniff & Goldfarb letter to shareholder for the third quarter 2015 discussing their long position in Valeant Pharmaceuticals. Get The Full Series in PDF Get the entire 10-part series on... read more